公司資料
iTeos Therapeutics 股價、新聞與催化劑
- 股票代碼:
- ITOS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Belgium and listed in the U
股價為何變動
Current closing-price context is not available for ITOS.
公司概覽
業務概覽
iTeos Therapeutics is an immuno-oncology company developing therapies that modulate the tumor microenvironment. Its pipeline is aimed at creating better cancer immunotherapy combinations.
所在地與產業分類
Headquartered in Belgium and listed in the U.S. as an ADR, iTeos has a global oncology-biotech profile.
商業模式特徵
The business depends on clinical data, partnership economics, and the ability to create differentiated oncology assets.
生技產業定位
iTeos is a catalyst-heavy immuno-oncology name whose stock reacts quickly to data and strategic developments.
未來催化劑
- iTeos Therapeutics's catalysts are belrestotug and the rest of its immuno-oncology pipeline, where the next clinical update will determine whether the platform still has momentum. The company remains very data-sensitive.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。